- Home
- ORIC vs DCOM Comparison
ORIC vs DCOM Comparison
Compare ORIC & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- DCOM
- Stock Information
- Founded
- ORIC 2014
- DCOM 1864
- Country
- ORIC United States
- DCOM United States
- Employees
- ORIC N/A
- DCOM N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- DCOM Major Banks
- Sector
- ORIC Health Care
- DCOM Finance
- Exchange
- ORIC Nasdaq
- DCOM Nasdaq
- Market Cap
- ORIC 1.1B
- DCOM 1.2B
- IPO Year
- ORIC 2020
- DCOM 1996
- Fundamental
- Price
- ORIC $13.16
- DCOM $26.25
- Analyst Decision
- ORIC Strong Buy
- DCOM Strong Buy
- Analyst Count
- ORIC 8
- DCOM 3
- Target Price
- ORIC $16.57
- DCOM $34.17
- AVG Volume (30 Days)
- ORIC 1.5M
- DCOM 211.3K
- Earning Date
- ORIC 11-06-2025
- DCOM 10-23-2025
- Dividend Yield
- ORIC N/A
- DCOM 3.81%
- EPS Growth
- ORIC N/A
- DCOM N/A
- EPS
- ORIC N/A
- DCOM 1.17
- Revenue
- ORIC N/A
- DCOM $340,529,000.00
- Revenue This Year
- ORIC N/A
- DCOM $49.66
- Revenue Next Year
- ORIC N/A
- DCOM $16.29
- P/E Ratio
- ORIC N/A
- DCOM $22.42
- Revenue Growth
- ORIC N/A
- DCOM 8.54
- 52 Week Low
- ORIC $3.90
- DCOM $23.25
- 52 Week High
- ORIC $14.93
- DCOM $37.60
- Technical
- Relative Strength Index (RSI)
- ORIC 54.79
- DCOM 33.43
- Support Level
- ORIC $12.75
- DCOM $25.92
- Resistance Level
- ORIC $13.80
- DCOM $29.66
- Average True Range (ATR)
- ORIC 0.72
- DCOM 1.08
- MACD
- ORIC -0.08
- DCOM -0.29
- Stochastic Oscillator
- ORIC 58.97
- DCOM 8.88
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.